<DOC>
	<DOCNO>NCT02784262</DOCNO>
	<brief_summary>Chronic rhinosinusitis ( CRS ) nasal polyp particularly challenge form chronic rhinosinusitis several way . Patients significantly severe symptom burden bad quality life patient chronic rhinosinusitis without nasal polyp . Many patient return health care provider persistent symptom repeat medical surgical treatment . Patients usually try several different type treatment , range less invasive procedure extensive surgical treatment . The surgical treatment often repeat several time . The common surgical treatment functional endoscopic sinus surgery , another establish procedure Vidian neurectomy . The main object pilot study investigate safety onabotulinumtoxin A towards sphenopalatine ganglion ( SPG ) CRS patient nasal polyp . Efficacy data also collect provide indication whether future placebo-controlled study perform . Onabotulinumtoxin A inhibits secretion acetylcholine , block parasympathetic reflex cascade SPG . As result , investigator expect less mucosal swelling , secretion nasal polyp . The duration blockade believe last 3-9 month lead damage nerve . This study open improve treatment less complication .</brief_summary>
	<brief_title>Botulinum Toxin Type A Block Sphenopalatine Ganglion Chronic Rhinosinusitis With Nasal Polyposis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Ganglion Cysts</mesh_term>
	<mesh_term>Synovial Cyst</mesh_term>
	<mesh_term>Nasal Polyps</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>write informed consent chronic rhinosinusitis nose polyp ( CRSwNP ) accord European position paper rhinosinusitis nasal polyp ( EPOS ) criteria satisfactory effect medicinal surgical treatment systemic local disease condition may result high risk complication psychiatric disorder indicate treatment pregnancy , breastfeeding , fertile female use contraception abuse drug , narcotic alcohol hypersensitivity marcain , lidocain , xylocain , adrenalin , similar drug anatomical condition hinder injection know sensitivity botulinum toxin type A adjuvant substance treatment drug interact botulinum toxin type A : suspicion polyp cause allergy suspicion Samters triade</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Botulinum Toxin Type A</keyword>
	<keyword>Block</keyword>
	<keyword>Sphenopalatine Ganglion</keyword>
</DOC>